Jürgen Schumacher
Director/Board Member bei SCIENTIFIC INDUSTRIES, INC.
Vermögen: 142 233 $ am 31.03.2024
Profil
Jürgen Schumacher is the founder of QIAGEN Srl (1984) and QIAGEN GmbH (1984).
He was also the founder of Algiax Pharmaceuticals GmbH (2011) where he served as the Chief Executive Officer from 2011 to 2019.
Dr. Schumacher is currently the Chief Executive Officer of SCT-Spinal Cord Therapeutics GmbH and an Independent Director at Scientific Industries, Inc. He obtained a doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Dr. Schumacher is also the founder of NewLab BioQuality AG.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
20.12.2023 | 80 131 ( 1,14% ) | 142 233 $ | 31.03.2024 |
Aktive Positionen von Jürgen Schumacher
Unternehmen | Position | Beginn |
---|---|---|
SCIENTIFIC INDUSTRIES, INC. | Director/Board Member | 29.04.2021 |
SCT-Spinal Cord Therapeutics GmbH
SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services SCT-Spinal Cord Therapeutics GmbH, a biopharmaceutical company based in Düsseldorf, Germany, is focused on the treatment of traumatic injury to the central nervous system. SCT`s proprietary key technology, the Regeneration Promoting Treatment, is an unique and promising treatment approach aimed at the supression of scar formation. The inhibition of scar formation allows the severed nerves to sprout and/or regenerate which in turn enables the recovery of sensory and motor function. As a first application of the Regeneration Promoting Treatment SCT is focusing on the development of Cordaneurin, a drug for the treatment of acute spinal cord injuries. In pre-clinical studies Cordaneurin has demonstrated its efficacy in the recovery of motor function after spinal cord contusion. | Chief Executive Officer | 23.11.2009 |
Ehemalige bekannte Positionen von Jürgen Schumacher
Unternehmen | Position | Ende |
---|---|---|
Algiax Pharmaceuticals GmbH
Algiax Pharmaceuticals GmbH BiotechnologyHealth Technology Algiax Pharmaceuticals GmbH operates as an independent biotechnology company. It discovers and develops products in the field of nervous system disease or dysfunction with a focus on neuropathic pain. The company was founded by Stefan Fischer, Jurgen Schumacher, Guido Koopmans and Birgit Hasse in April 2011 and is headquartered in Erkrath, Germany. | Chief Executive Officer | 01.05.2019 |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Founder | - |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy. | Founder | - |
NewLab BioQuality AG
NewLab BioQuality AG Medical/Nursing ServicesHealth Services Part of Charles River Laboratories International, Inc., NewLab BioQuality AG is a laboratory services provider that specializes in the analysis of biopharmaceutical drugs. The private company is based in Erkrath, Germany. The German company was founded by Jürgen Schumacher. Jürgen Schumacher has been the CEO since incorporation. NewLab BioQuality was acquired by Charles River Laboratories International, Inc. on September 09, 2008 for $52.65 million. | Founder | - |
Ausbildung von Jürgen Schumacher
Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCIENTIFIC INDUSTRIES, INC. | Producer Manufacturing |
Private Unternehmen | 5 |
---|---|
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Commercial Services |
NewLab BioQuality AG
NewLab BioQuality AG Medical/Nursing ServicesHealth Services Part of Charles River Laboratories International, Inc., NewLab BioQuality AG is a laboratory services provider that specializes in the analysis of biopharmaceutical drugs. The private company is based in Erkrath, Germany. The German company was founded by Jürgen Schumacher. Jürgen Schumacher has been the CEO since incorporation. NewLab BioQuality was acquired by Charles River Laboratories International, Inc. on September 09, 2008 for $52.65 million. | Health Services |
SCT-Spinal Cord Therapeutics GmbH
SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services SCT-Spinal Cord Therapeutics GmbH, a biopharmaceutical company based in Düsseldorf, Germany, is focused on the treatment of traumatic injury to the central nervous system. SCT`s proprietary key technology, the Regeneration Promoting Treatment, is an unique and promising treatment approach aimed at the supression of scar formation. The inhibition of scar formation allows the severed nerves to sprout and/or regenerate which in turn enables the recovery of sensory and motor function. As a first application of the Regeneration Promoting Treatment SCT is focusing on the development of Cordaneurin, a drug for the treatment of acute spinal cord injuries. In pre-clinical studies Cordaneurin has demonstrated its efficacy in the recovery of motor function after spinal cord contusion. | Commercial Services |
Algiax Pharmaceuticals GmbH
Algiax Pharmaceuticals GmbH BiotechnologyHealth Technology Algiax Pharmaceuticals GmbH operates as an independent biotechnology company. It discovers and develops products in the field of nervous system disease or dysfunction with a focus on neuropathic pain. The company was founded by Stefan Fischer, Jurgen Schumacher, Guido Koopmans and Birgit Hasse in April 2011 and is headquartered in Erkrath, Germany. | Health Technology |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy. | Health Technology |